Evidence map›Paper›PMID 42966891›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

RUNX1-Mediated Hypoxic Signaling Impairs Myogenesis and Promotes Fibrosis in Myopathies.

Liang Zhao, Taijiang Hou, Lin Zhang, Feng Gao, Tong Xing

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Liang Zhao *College of Animal Science and Technology, Nanjing Agricultural University, Nanjing, Jiangsu, China.
Taijiang Hou *College of Animal Science and Technology, Nanjing Agricultural University, Nanjing, Jiangsu, China.ORCID https://orcid.org/0009-0003-1524-4059
Lin ZhangCollege of Animal Science and Technology, Nanjing Agricultural University, Nanjing, Jiangsu, China.ORCID https://orcid.org/0000-0003-1555-1086
Feng GaoCollege of Animal Science and Technology, Nanjing Agricultural University, Nanjing, Jiangsu, China.
Tong XingCollege of Animal Science and Technology, State Key Laboratory of Meat Quality Control and Cultured Meat Development, Nanjing Agricultural University, Nanjing, Jiangsu, China.ORCID https://orcid.org/0000-0003-1561-4614

Funding

Fundamental Research Funds for the Central Universities YDZX2026007National Key Research and Development Program of China 2023YFD1301304National Natural Science Foundation of China 32272900National Natural Science Foundation of China 32573161Natural Science Foundation of Jiangsu Province BK20252059
6 · The paper itself

Abstract

Compromised myogenic repair with enhanced fibrosis is common in myopathies, including Wooden Breast (WB) myopathy in broilers, but the underlying mechanism of their co-occurrence remains elusive. Using WB myopathy as a model, we investigated the common pathological origins of these co-occurring features. Our single-nucleus RNA sequencing results showed enhanced oxidative stress and profibrotic remodeling of myofibers, increased proliferation but decreased differentiation of satellite cells (SCs), and aggravated differentiation of fibroblasts (FBs) in WB samples. Differential gene expression and pseudotime trajectory analysis further identified RUNX1 as a key regulator for both SCs and FBs, which was further supported by gene functional studies in respective cell culture models. Moreover, reduced blood flow and oxygen supply may indicate a hypoxic state in WB muscle, which was associated with enhanced RUNX1 expression. Consistently, coordinately enhanced HIF1A and RUNX1 expressions were found in differentiated FBs of human muscles and in muscles with diseases. Collectively, our study found that hypoxia-associated upregulation of RUNX1 disrupted the myogenic progression of SCs and exacerbated fibrotic differentiation of FBs, contributing to pathological degeneration in myopathies. Targeting RUNX1 may therefore represent a potential therapeutic strategy for prevention and treatment, which warrants future in vivo investigations.

Indexed as

fibrosishypoxiamyogenic repairmyopathyRUNX1

Identifiers

PMID42966891
PMCPMC13723716

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.